Shanghai, China, January 4, 2021 – Arctic Vision, a clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, today announced that Dr. Eddy Wu, founder and CEO of Arctic Vision, will participate in the 39th Annual J.P. Morgan Healthcare Conference in January 2021. Further details as below:
39th Annual J.P. Morgan Healthcare Conference
One on one meeting: January 13 and 14, 2021 CST
Participant: Dr. Eddy Wu, Founder & CEO of Arctic Vision
For more information, please consult your J.P. Morgan representative.
About Arctic Vision
Arctic Vision is a China-based clinical stage specialty ophthalmology company with a leading portfolio of breakthrough technologies. The company’s vision is to address ophthalmology’s unmet needs through innovative therapies in China, Asia and globally. Arctic Vision is established by top-tier life sciences investors, and led by an elite team of ophthalmic industry veterans with substantial and compelling China and global experiences in R&D and commercialization of eye care products. For more information, please visit www.arcticvision.com, or follow us on WeChat: ArcticVision.
